"Burkholderia cepacia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of BURKHOLDERIA considered to be an opportunistic human pathogen. It has been associated with various types of infections of nosocomial origin.
Descriptor ID |
D016956
|
MeSH Number(s) |
B03.660.075.090.688.100.110.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Burkholderia cepacia".
Below are MeSH descriptors whose meaning is more specific than "Burkholderia cepacia".
This graph shows the total number of publications written about "Burkholderia cepacia" by people in this website by year, and whether "Burkholderia cepacia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 1 | 0 | 1 |
2013 | 1 | 0 | 1 |
2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Burkholderia cepacia" by people in Profiles.
-
Karlowsky JA, Hackel MA, Tsuji M, Yamano Y, Echols R, Sahm DF. In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, Against Gram-Negative Bacilli Isolated by Clinical Laboratories in North America and Europe in 2015-2016: SIDERO-WT-2015. Int J Antimicrob Agents. 2019 Apr; 53(4):456-466.
-
Reddy JC, Tibbetts MD, Hammersmith KM, Nagra PK, Rapuano CJ. Successful management of Burkholderia cepacia keratitis after LASIK. J Refract Surg. 2013 Jan; 29(1):8-9.
-
Critchley IA, Sahm DF, Kelly LJ, Karlowsky JA. In vitro synergy studies using aztreonam and fluoroquinolone combinations against six species of Gram-negative bacilli. Chemotherapy. 2003 May; 49(1-2):44-8.